Renaissance Technologies - INNOVATE BIOPHARMACEUTICLS I ownership

Back to all holdings Add to watchlist

INNOVATE BIOPHARMACEUTICLS I's ticker is INNT and the CUSIP is 45782F105. A total of 22 filers reported holding INNOVATE BIOPHARMACEUTICLS I in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Renaissance Technologies ownership history of INNOVATE BIOPHARMACEUTICLS I
ValueSharesWeighting
Q1 2020$113,000
+189.7%
225,399
+221.5%
0.00%–
Q4 2019$39,000–70,100–0.00%–
 Download
Other shareholders

There were no reported owners of INNOVATE BIOPHARMACEUTICLS I in Q4 2019.

NameSharesValueWeighting ↓
View complete list of INNOVATE BIOPHARMACEUTICLS I shareholders